The International Coalition of Medicines Regulatory Authorities (ICMRA), a voluntary coalition of regulatory leaders that provides strategic directions for enhanced cooperation, improved communication, and effective global crisis response mechanisms, and the World Health Organization (WHO) have issued a call for the pharmaceutical industry to provide wide access to clinical data for all new medicines […]

A Yale-led study reveals that new medicines and vaccines approved for use in the United States are often unavailable in countries that hosted their clinical trials, suggesting that the benefits of drug research are not being shared equitably among populations that participate in testing. The study, published May 5 in JAMA Network Open, covers 34 […]